公司资料
Myomo 股价、新闻与催化剂
- 股票代码:
- MYO
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
1.57 USD (-8.72%)
收盘价
最后更新: 2026年8月17日
41M USD
市值
股价为何变动
As of Aug 17, 2026, MYO closed down 8.72% at $1.57. No new same-company headline was identified in the current news window.
公司概览
业务概览
Myomo is a medical robotics company focused on powered orthotic devices that help patients with upper-limb impairment. Its business is centered on assistive technology rather than biotech therapeutics.
所在地与行业分类
Myomo is headquartered in the United States and listed on NYSE American. It sits in medical devices and rehabilitation technology.
商业模式特征
The company depends on product adoption, reimbursement, and the ability to scale its assistive-device platform. Investors watch commercial execution, insurance access, and unit growth.
生物医药行业定位
Myomo is outside biotech and belongs in the rehab-device category. Its stock is driven by device adoption and reimbursement rather than drug or trial catalysts.
未来催化剂
- Myomo’s catalysts are assistive-device adoption, reimbursement, and continued growth in neuro-orthopedic support. The business improves when the device base keeps widening.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。